Cancer Incidence and Mortality for Livingston County, 2012-2016

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 393.8 492.9 470.6-516.0 213.2 557.3 523.2-593.1 180.6 442.3 412.5-473.9 136.0 167.8 155.2-181.3 72.2 197.2 176.9-219.3 63.8 144.4 128.4-162.0
Oral cavity and pharynx 7.8 10.3 7.2-14.4 5.6 15.2 9.9-22.4 2.2 5.4 2.5-10.3 2.0 2.6 1.2-4.9 1.2 3.4 1.2-7.6 0.8 1.8 0.5-5.1
Esophagus 5.4 6.4 4.2-9.5 4.2 11.6 7.1-18.0 1.2 2.4 0.9-5.8 3.8 4.4 2.6-7.2 2.8 7.4 3.9-12.9 1.0 2.0 0.6-5.3
Stomach 4.4 5.4 3.3-8.3 3.0 7.6 4.2-13.0 1.4 3.4 1.3-7.5 1.8 2.2 1.0-4.4 0.6 1.7 0.3-5.3 1.2 2.7 1.0-6.4
Colorectal 33.4 41.6 35.3-48.8 19.0 50.2 40.2-61.9 14.4 34.2 26.4-43.8 12.4 15.6 11.9-20.2 7.2 20.1 13.9-28.2 5.2 12.2 7.8-18.5
Colon excluding rectum 22.8 29.2 23.9-35.4 13.4 36.3 27.8-46.6 9.4 22.9 16.6-31.1 11.2 14.0 10.5-18.3 6.4 18.1 12.3-25.9 4.8 10.7 6.7-16.5
Rectum & rectosigmoid 10.6 12.4 9.2-16.5 5.6 13.9 9.1-20.5 5.0 11.3 7.2-17.3 1.2 1.6 0.6-3.8 0.8 2.0 0.5-5.5 0.4 1.5 0.2-5.3
Liver / intrahepatic bile duct 5.6 7.0 4.6-10.3 3.6 9.5 5.5-15.3 2.0 5.1 2.3-10.0 5.2 6.5 4.2-9.7 3.2 8.6 4.9-14.3 2.0 4.5 2.1-8.8
Pancreas 8.8 10.8 7.8-14.7 4.8 12.8 8.1-19.5 4.0 9.1 5.4-14.5 8.0 9.2 6.6-12.8 3.8 9.7 5.7-15.5 4.2 8.5 5.2-13.5
Larynx 2.0 2.2 1.1-4.3 1.4 3.2 1.2-7.0 0.6 1.4 0.3-4.7 1.2 1.5 0.6-3.5 1.2 3.5 1.3-7.8 0.0 0.0 0.0-2.6
Lung and bronchus 58.0 70.5 62.5-79.4 33.0 85.6 72.7-100.3 25.0 57.8 48.0-69.4 40.8 49.5 42.8-57.0 24.0 63.1 52.0-76.0 16.8 37.9 30.1-47.4
Melanoma of the skin 20.6 27.5 22.2-33.7 13.4 36.9 28.3-47.4 7.2 19.4 13.2-27.7 1.6 2.2 0.9-4.4 1.2 3.7 1.4-8.2 0.4 0.9 0.1-3.9
Female breast             54.4 136.4 119.8-154.7             9.2 20.4 14.6-27.9
Cervix uteri             2.0 8.1 3.7-14.9             1.0 2.7 0.8-6.8
Corpus uterus and NOS             11.4 26.1 19.6-34.3             1.2 2.5 0.9-6.1
Ovary             6.6 16.6 11.2-23.8             5.2 11.6 7.5-17.4
Prostate       55.2 131.0 115.6-148.0             4.8 13.6 8.6-20.5      
Testis       1.6 5.1 2.1-10.4             0.0 0.0 0.0-2.5      
Urinary bladder (incl. in situ) 20.2 24.9 20.2-30.5 15.4 41.7 32.7-52.5 4.8 11.1 7.0-17.0 5.4 6.6 4.4-9.8 4.6 13.0 8.2-19.8 0.8 1.9 0.5-5.5
Kidney and renal pelvis 14.4 17.9 13.8-22.8 10.0 25.7 18.8-34.3 4.4 10.9 6.6-17.2 1.8 2.5 1.1-5.0 1.0 3.1 1.0-7.5 0.8 2.2 0.5-6.1
Brain and other central nervous system 6.6 9.1 6.2-13.0 3.8 10.8 6.4-17.3 2.8 7.1 3.8-12.5 5.2 6.7 4.3-10.0 2.2 5.4 2.6-10.1 3.0 7.7 4.1-13.2
Thyroid 8.2 12.1 8.5-16.7 3.2 9.4 5.3-15.7 5.0 15.0 9.4-22.7 0.2 0.2 0.0-1.6 0.0 0.0 0.0-2.5 0.2 0.4 0.0-3.2
Hodgkin lymphoma 1.0 1.2 0.4-3.0 1.0 2.5 0.8-6.3 0.0 0.0 0.0-2.6 0.0 0.0 0.0-1.3 0.0 0.0 0.0-2.5 0.0 0.0 0.0-2.6
Non-Hodgkin lymphomas 16.8 20.3 16.1-25.4 8.8 22.4 16.2-30.6 8.0 18.2 12.9-25.2 4.2 5.2 3.2-8.1 2.6 7.5 4.0-13.1 1.6 3.4 1.4-7.3
Myeloma 3.8 4.6 2.7-7.4 1.0 2.6 0.8-6.5 2.8 6.7 3.5-11.8 1.0 1.1 0.4-2.9 0.2 0.4 0.0-3.1 0.8 1.8 0.5-5.1
Leukemias 13.8 17.9 13.8-22.9 7.4 21.1 14.7-29.4 6.4 14.8 9.8-21.7 5.2 6.7 4.3-10.1 2.8 8.0 4.3-13.6 2.4 6.0 2.9-11.1

Notes

  • Incidence data are provisional, November 2018.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.